National Vision price to book ratio EYE

Market value divided by the book value of the company's net assets, since 2017.

Today, Oct 23, 2026: 1.6×
9-year median: 2.8×
Against its 9-year history: 17th; percentile: 0 is its lowest day, 100 its highest
9-year range: 0.9× to 12.6×
Peer median: 4.8×

National Vision's price to book ratio is 1.6× as of Oct 23, 2026.

That is below its 9-year median of 2.8×, lower than on 83% of days in the last 9 years.

Over that time it ranged from 0.9× in Sep 2024 to 12.6× in Jan 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 4.8×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	1.6×	1.4×	2.7×
2025	2.6×	1.0×	2.7×
2024	1.0×	0.9×	2.2×
2023	1.9×	1.2×	3.7×
2022	3.4×	2.2×	3.9×
2021	4.0×	3.9×	5.7×
2020	4.2×	1.5×	4.4×
2019	3.4×	2.3×	3.7×
2018	2.9×	2.7×	12.6×
2017	11.9×	9.7×	11.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest National Vision's size, closest first, today.

Company	Price to book ratio
EYENational Vision	1.6×
CDRECadre	3.7×
BVSBioventus	5.5×
STAAStaar Surgical	3.1×
LMATLemaitre Vascular	4.6×
IRMDIradimed	10.8×
INSPInspire Medical Systems	2.5×
UFPTUFP Technologies	5.0×
ATRCAtriCure	5.8×
MOVMovado	1.4×
WRBYWarby Parker	8.2×
Peer median	4.8×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on National Vision

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.